
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1802 | -60.0266489007 | 0.3002 | 0.315764 | 0.11 | 9702538 | 0.13011369 | CS |
4 | -0.227 | -65.4178674352 | 0.347 | 0.347 | 0.11 | 2315937 | 0.14888141 | CS |
12 | -0.26 | -68.4210526316 | 0.38 | 0.446 | 0.11 | 970045 | 0.20083594 | CS |
26 | -0.41 | -77.358490566 | 0.53 | 0.608 | 0.11 | 761390 | 0.30569553 | CS |
52 | -0.56 | -82.3529411765 | 0.68 | 0.87 | 0.11 | 608402 | 0.40679395 | CS |
156 | -2.04 | -94.4444444444 | 2.16 | 5.95 | 0.11 | 496300 | 1.37302225 | CS |
260 | -16.88 | -99.2941176471 | 17 | 35.6 | 0.11 | 570242 | 2.97908197 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions